참고문헌
- Stern RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 2010;146:279-82. https://doi.org/10.1001/archdermatol.2010.4
- Rubio-Casadevall J, Hernandez-Pujol AM, Ferreira-Santos MC, et al. Trends in incidence and survival analysis in nonmelanoma skin cancer from 1994 to 2012 in Girona, Spain: a population-based study. Cancer Epidemiol 2016;45:6-10. https://doi.org/10.1016/j.canep.2016.09.001
- Xiang F, Lucas R, Hales S, Neale R. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. JAMA Dermatol 2014;150:1063-71. https://doi.org/10.1001/jamadermatol.2014.762
- Wassberg C, Thorn M, Johansson AM, Bergstrom R, Berne B, Ringborg U. Increasing incidence rates of squamous cell carcinoma of the skin in Sweden. Acta Derm Venereol 2001;81:268-72. https://doi.org/10.1080/00015550152572903
- Hemminki K, Zhang H, Czene K. Time trends and familial risks in squamous cell carcinoma of the skin. Arch Dermatol 2003;139:885-9. https://doi.org/10.1001/archderm.139.7.885
- Eisemann N, Jansen L, Castro FA, et al. Survival with nonmelanoma skin cancer in Germany. Br J Dermatol 2016;174:778-85. https://doi.org/10.1111/bjd.14352
- Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 2013;149:541-7. https://doi.org/10.1001/jamadermatol.2013.2139
- Hernandez-Machin B, Borrego L, Gil-Garcia M, Hernandez BH. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol 2007;46:453-9. https://doi.org/10.1111/j.1365-4632.2006.03108.x
- Grossi Marconi D, da Costa Resende B, Rauber E, et al. Head and neck non-melanoma skin cancer treated by superficial X-ray therapy: an analysis of 1021 cases. PLoS One 2016;11:e0156544. https://doi.org/10.1371/journal.pone.0156544
- National Comprehensive Cancer Network. NCCN Guidelines: squamous cell skin cancer [Internet]. Plymouth Meeting, PA: National Comprehensive Cancer Network; c2019 [cited 2019 May 30]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf.
- Kil WJ, Camphausen K. Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities. Head Neck 2017;39:E55-E60. https://doi.org/10.1002/hed.24700
- Chen AM, Vaughan A, Narayan S, Vijayakumar S. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme. Head Neck 2008;30:1586-91. https://doi.org/10.1002/hed.20894
- Paris KJ, Spanos WJ Jr, Lindberg RD, Jose B, Albrink F. Phase I-II study of multiple daily fractions for palliation of advanced head and neck malignancies. Int J Radiat Oncol Biol Phys 1993;25:657-60. https://doi.org/10.1016/0360-3016(93)90012-k
- Corry J, Peters LJ, Costa ID, et al. The 'QUAD SHOT': a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother Oncol 2005;77:137-42. https://doi.org/10.1016/j.radonc.2005.10.008
- Lok BH, Jiang G, Gutiontov S, et al. Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. Oral Oncol 2015;51:957-62. https://doi.org/10.1016/j.oraloncology.2015.07.011
피인용 문헌
- The Role of Postoperative Radiotherapy and Prognostic Model in Primary Squamous Cell Carcinoma of Parotid Gland vol.10, 2019, https://doi.org/10.3389/fonc.2020.618564
- Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot vol.10, pp.13, 2019, https://doi.org/10.1002/cam4.3646